Drugs that contain Ondansetron

1. Drug name - ZUPLENZ

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8580830 AQUESTIVE Non-mucoadhesive film dosage forms Nov, 2029

(7 years from now)

US9095577 AQUESTIVE Stabilized amine-containing actives in oral film compositions Jul, 2030

(7 years from now)

Treatment: NA


More Information on Dosage
Strength Dosage Availability
4MG FILM;ORAL Discontinued
8MG FILM;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.